Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Spironolactone 20mg/5ml oral liquid
0202030S0AADDDD
|
Spironolactone | Spironolactone | Cardiovascular System | No data available |
|
Spironolactone 2mg/5ml oral liquid
0202030S0AADUDU
|
Spironolactone | Spironolactone | Cardiovascular System | No data available |
|
Spironolactone 3.3mg/5ml oral liquid
0202030S0AADXDX
|
Spironolactone | Spironolactone | Cardiovascular System | No data available |
|
Spironolactone 3.5mg/5ml oral liquid
0202030S0AADTDT
|
Spironolactone | Spironolactone | Cardiovascular System | No data available |
|
Spironolactone 30mg/5ml oral liquid
0202030S0AACUCU
|
Spironolactone | Spironolactone | Cardiovascular System | No data available |
|
Spironolactone 35mg/5ml oral liquid
0202030S0AADGDG
|
Spironolactone | Spironolactone | Cardiovascular System | No data available |
|
Spironolactone 3mg/5ml oral liquid
0202030S0AADMDM
|
Spironolactone | Spironolactone | Cardiovascular System | No data available |
|
Spironolactone 4.5mg/5ml oral liquid
0202030S0AADLDL
|
Spironolactone | Spironolactone | Cardiovascular System | No data available |
|
Spironolactone 40mg/5ml oral liquid
0202030S0AADIDI
|
Spironolactone | Spironolactone | Cardiovascular System | No data available |
|
Spironolactone 4mg/5ml oral liquid
0202030S0AACWCW
|
Spironolactone | Spironolactone | Cardiovascular System | No data available |
|
Spironolactone 6.25mg/5ml oral liquid
0202030S0AACTCT
|
Spironolactone | Spironolactone | Cardiovascular System | No data available |
|
Spironolactone 6mg/5ml oral liquid
0202030S0AADQDQ
|
Spironolactone | Spironolactone | Cardiovascular System | No data available |
|
Spironolactone 7.5mg/5ml oral liquid
0202030S0AACVCV
|
Spironolactone | Spironolactone | Cardiovascular System | No data available |
|
Spironolactone 75mg/5ml oral liquid
0202030S0AADEDE
|
Spironolactone | Spironolactone | Cardiovascular System | No data available |
|
Spironolactone 7mg/5ml oral liquid
0202030S0AACYCY
|
Spironolactone | Spironolactone | Cardiovascular System | No data available |
|
Spironolactone 8.3mg/5ml oral liquid
0202030S0AADVDV
|
Spironolactone | Spironolactone | Cardiovascular System | No data available |
|
Spironolactone 8mg/5ml oral liquid
0202030S0AADBDB
|
Spironolactone | Spironolactone | Cardiovascular System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.